Coronaviruses encode multiple interferon antagonists that modulate the host response to 19 virus replication. Here, we evaluated pathogenesis and host transcription in response to infection 20 with murine coronaviruses encoding independent mutations in two different viral antagonists: the 21 deubiquitinase (DUB) within nonstructural protein 3 and the endoribonuclease (EndoU) within 22 nonstructural protein 15. The virus with reduced ability to deubiquitinate proteins, herein termed 23 the DUBmut virus, was engineered via X-ray structure-guided mutagenesis and activates an earlier 24 interferon response than the wild type virus. However, the replication kinetics of DUBmut in 25 cultured cells are similar to wild type virus and pathogenesis in mice is also similar to what was 26 observed during infection with wild type virus. On the other hand, we previously reported that an 27 EndoUmut virus containing an inactivated endoribonuclease activity elicited rapid and robust 28 activation of type I interferon, which limited virus replication and pathogenesis. Here, using a 29 transcriptomics approach, we compared the scope and kinetics of the host response to the wild 30 type, DUBmut, and EndoUmut viruses in infected macrophages. We found that the EndoUmut 31 virus activates a focused response, predominantly involving type I interferons and a subset of 32 interferon-responsive genes, within 12 hours after infection. In contrast, the wild type and 33 DUBmut viruses stimulate upregulation of over 2,800 genes, including activation of unfolded 34 protein response (UPR) pathways and a proinflammatory profile associated with viral 35 pathogenesis. This study highlights the role of viral interferon antagonists in shaping the kinetics 36 and magnitude of the host response during virus infection and demonstrates that inactivation of a 37 dominant viral antagonist, the coronavirus endoribonuclease, dramatically alters the host response 38 in macrophages and the disease process. 39 3 40
Introduction 59
The ability to evade or delay activation of host innate and adaptive immune responses is now 60 recognized as a characteristic of many pathogenic viruses. Viruses from diverse families, including 61 filoviruses [1], poxviruses [2], influenza viruses [3] , flaviviruses [4] , and coronaviruses [5, 6] , 62 encode proteins that are not required for viral replication per se, but act as modulators of initial, bonds with the backbone carbonyl oxygen of A46 in ubiquitin ( Fig 1B) . The two side chain 139 carboxylate oxygens of D1772 in MHV PLP2 interact with ubiquitin by forming direct bonds with 140 each of the guanidinium nitrogens of R42 and with one of the guanidinium nitrogens of R72 (Fig   141   1C ). Finally, F1812 forms Van der Waals contacts with the side chains of I44 and V70 and the 142 delta-carbon of R42 of ubiquitin ( Fig 1D) . 143 To identify a mutant MHV PLP2 enzyme that retains protease activity but exhibits reduced 144 DUB and/or deISGylating activity, we performed site-directed mutagenesis on each of the residues 145 (R1803, D1772, F1812) by changing each to an alanine to disrupt interactions with ubiquitin. Each 146 mutant enzyme was expressed, purified, and tested for its ability to hydrolyze three substrates: z-147 RLRGG-AMC, Ub-AMC, and ISG15-AMC. The activity of each mutant enzyme toward each 148 substrate relative to the wild type enzyme is shown in Fig 2A. All three mutants retained their 149 ability to hydrolyze the peptide substrate but each mutant had altered specificity toward Ub-AMC Since one of the primary goals of this study is to understand the contribution of DUB 155 activity to viral replication and pathogenesis, we next focused on quantitating further the effects 156 of the D1772A mutant on the steady-state kinetic parameters of MHV PLP2 toward the three 157 different substrates ( Fig 2B) . The RLRGG-AMC peptide substrate is often used as surrogate of 158 the viral polyprotein substrate and the kinetic data in Fig 2B show that this substrate is still well-159 recognized and cleaved by the D1772A mutant. In fact, we observed a small rate enhancement in 160 the catalytic efficiency (i.e., k cat /K m ) compared to the wild type enzyme.
161
The Ub-AMC substrate, on the other hand, is poorly recognized and cleaved by the 162 D1772A compared to the wild type enzyme. The wild type enzyme normally interacts strongly 163 with Ub-AMC with a K m value of 0.67 µM. However, mutation of D1772 to an alanine 164 significantly disrupts the interaction with ubiquitin, making it impossible to saturate MHV PLP2 165 under normal experimental conditions ( Fig 2B) . The net result is a significant reduction in the 166 catalytic efficiency (k cat /K m ) compared to the wild type enzyme, which was the goal of these trials.
167
The kinetic response of MHV PLP2 toward another substrate, ISG15-AMC, was also 168 determined. ISG15 is an important ubiquitin-like modifier that is upregulated and used to ISGylate 169 host proteins during viral infection. A number of viruses, including coronaviruses, engender 170 ISGylation during infection but the function(s) and importance of this activity are not clear. For 171 MHV, neither the wild type nor the D1772A mutant PLP2 enzyme can be saturated with ISG15-
172
AMC, suggesting weak binding with this ubiquitin-like modifier ( Fig 2B) . Moreover, the R1772A 173 mutation does not disrupt the interaction with ISG15 but in fact enhances it to some degree. A 174 potential explanation for the observed selective disruption of ubiquitin binding stems from our 175 analysis of a primary sequence alignment of ubiquitin and ISG15 and the residues that interact 176 with D1772 ( Fig 2C) . The interaction between MHV PLP2 D1772 and the R42 residue in human 9 177 and mouse ubiquitin is absent in human and mouse ISG15 since this residue is a tryptophan in 178 human and mouse ISG15. Therefore, in line with our observations, D1772A mutation would not 179 be expected to alter ISG15 binding. In contrast to R42, residue R72 is conserved in both ubiquitin 180 and ISG15 and its interaction with MHV PLP2 for ubiquitin is likely weaker than that with ISG15.
181
The in vitro biochemical studies presented here support the notion that we are able to use 182 a structure-guided approach to uncouple the DUB enzymatic activity from MHV PLP2 while 183 preserving the peptide hydrolysis and deISGylating activities of PLP2. Next, we focused on 184 comparing the activity of the mutant enzyme to its wild type counterpart for the ability to remove 185 Flag-tagged-ubiquitin conjugated to host proteins in cultured cells ( Fig 3A) . We found that in cells, 186 wild type PLP2 exhibits robust DUB activity and removes ubiquitin modifications from multiple 187 cellular proteins. On the other hand, the PLP2-D1772A mutant exhibits reduced DUB activity, 188 similar to that of the previously documented catalytic cysteine to alanine mutant, PLP2-CA [22] .
189
To determine if this impaired DUB activity altered the ability of PLP2/DUB to act as an interferon 190 antagonist, we transfected cells with RIG-I, an interferon-luciferase reporter, and either wild type 191 or mutant PLP2 and measured luciferase activity at 18 hours post-transfection. In agreement with 192 previous reports, we find that wild type PLP2/DUB acts as an interferon antagonist, reducing 193 reporter activity by 50-80%. In contrast, PLP2-D1772A is unable to significantly reduce interferon 194 activation in this assay despite similar expression levels of the wild type and mutant versions of 195 the protein ( Fig 3B) . We also evaluated the protease activity of the enzymes in cells using two 196 independent trans-cleavage assays and found that the wild type and DUB-mutant enzymes produce 197 similar levels of cleaved products. These results indicate that the D1772A substitution did not alter 198 protease activity ( Fig 3C and D) , in agreement with the in vitro kinetic results described above 10 199 ( Fig 2) . Together, these studies reveal that aspartic acid residue 1772 of MHV-PLP2 is important 200 for DUB-mediated interferon antagonism, but not for protease activity.
201
Since the D1772A substitution did not impact protease activity, we reasoned that we should parallel with wild type virus, we found that DUBmut replicates with essentially identical kinetics 209 as the wild type in a murine astrocytoma cell line (DBT cells) ( Fig 4A) . These results are consistent 210 with previous studies of coronavirus interferon antagonists, which showed in many cell lines that 211 viral-mediated interferon antagonism is not essential for virus replication [10, 11] .
212
To determine if the impaired DUB activity of the DUBmut virus had an effect on interferon 213 antagonism, we infected primary bone marrow-derived macrophages (BMDMs) and evaluated 214 viral replication kinetics and levels of interferon mRNA and protein. We observed significant 215 activation of interferon alpha (IFN) mRNA expression ( Fig 4A) that is coupled with release of 216 IFN protein into the supernatant, as detected by ELISA ( Fig 4B) . We show that this activation of 217 IFN is dependent on expression of pattern recognition receptor MDA5 ( Fig 4D) , in agreement 218 with previous reports [10, 11] . To our surprise, we found that replication of DUBmut is not 219 impaired relative to wild type in BMDMs, as measured by level of nucleocapsid RNA ( Fig 4E) 220 and evaluation of infectious virus particle production over time in the kinetics assay ( Fig 4F) . 221 These results demonstrate that an elevated interferon response is generated during replication of 11 222 the DUBmut virus, but that this interferon profile is not associated with reduced production of 223 infectious particles in either DBT cells or BMDMs.
224
Disrupting DUB activity is mildly attenuating to coronavirus pathogenesis in mice. 225 To complement our in vitro studies, we next sought to determine whether loss of DUB 226 activity and the observed activation of interferon during DUBmut infection in macrophages is 227 associated with an attenuated phenotype in mice. To test this, we inoculated mice intra-peritoneally 228 with 6×10 4 plaque-forming units (pfu) of the designated virus and measured viral titer in the liver 229 and spleen at the indicated days post-infection (dpi). We detected similar levels of infectious 230 particles at 3 dpi, but reduced levels of infectious particles in the livers and spleens of DUBmut-231 infected mice at 5 dpi ( Fig 5A) . Similar pathology in liver sections was observed at 3 and 5 dpi 232 ( Fig 5B) . These results suggest that the DUBmut virus is mildly attenuated compared to the wild 233 type virus when evaluated using the intraperitoneal route of infection. We also used the more 234 sensitive intracranial infection model to evaluate pathogenesis and found similar lethality among 235 WT and DUBmut-infected mice ( Fig 5C) . We were surprised at the similarities between wild type 236 and DUBmut infection in vivo since our previous study involving inactivation of a different viral 237 interferon antagonist, EndoU, revealed profound attenuation and rapid clearance of an EndoU-238 mutant virus from infected mice [10] . Having shown that the DUBmut and the EndoUmut viruses 239 each activate an innate immune response, we expected that infection of mice with either mutant 240 virus would lead to similar outcomes. Therefore, as our expectations for the DUBmut virus were 241 in stark contrast to what we observed, we next performed transcriptome profiling of infected 242 macrophages at multiple time points in order to build a more complete understanding of the host 243 response to the wild type virus, DUBmut virus, and the highly attenuated EndoUmut virus.
244
Transcriptome profiling reveals differences in kinetics and magnitude of host responses to 245 mutant viruses. 246 BMDMs were infected with the designated virus and total RNA was harvested for RNA-247 seq transcriptome profiling at 3, 6, 9, and 12 hours post-infection (hpi). Using the RNA-seq data, 248 we identified differentially expressed genes by applying a cutoff of at least 4-fold elevated 249 expression in wild type-infected cells at 12 hpi over mock (q < 0.05). We then utilized Cluster 3.0 250 software to visualize overall patterns of gene expression between all groups across all time points 251 ( Fig 6) . These analyses reveal significant differences in overall patterns of gene expression 252 between the EndoUmut-infected cells and wild type virus-infected cells, whereas the gene 253 expression profile induced by the DUBmut virus is remarkably similar to wild type virus infection 254 ( Fig 6) . More specifically, 2,879 genes are significantly transcriptionally activated (>4-fold, q < 255 0.05) in wild type-and DUBmut-infected macrophages by 12 hpi when compared to mock-256 infected macrophages. Interestingly, our analyses also identified a subset of 231 genes, indicated 257 by the bracket in Figure 6 , that were most highly upregulated in EndoUmut-infected cells. It is 258 important to note that these genes were also induced during WT and DUBmut infections, but not 259 to the same magnitude as detected in the EndoUmut-infected cells. We next sought to functionally 260 cluster these 231 genes as a means of investigating the respective host transcriptional response to 261 each mutant virus.
262
EndoUmut infection activates genes associated with an antiviral response. 263 Using an online tool called Database for Annotation, Visualization and 264 Integrated Discovery (DAVID) to cluster the 231 genes bracketed in Figure 6 based on functional 265 similarities [24, 25] , we find that the protein products of these genes are predominantly involved 266 in antiviral and signaling pathways. Notably, the DAVID analyses reveal a subset of 30 unique 267 genes, including several interferon isoforms, which are clustered together into statistically 13 268 significant pathways associated with the immune response and signaling cascades ( Fig 7A) . 269 Interestingly, the heat map of these genes reveals a similar temporal trend in upregulation of IFN 270 gene expression during infection with each of the three viruses; however, this expression profile 271 is by far the most pronounced in the EndoUmut-infected cells. In this heatmap view, as in Figure   272 6, it is difficult to ascertain any difference in expression of IFN genes between wild type-and 273 DUBmut-infected cells; therefore, to obtain more information on the kinetics of transcriptional 274 activation between groups, we quantitated the reads associated with each gene and graphically 275 display the normalized read counts in Figure 7B these genes in DUBmut-and WT-infected BMDMs are strikingly similar (Figs 6 and 7) . We 293 therefore propose that the comparable outcomes of infection observed in DUBmut-and WT-294 infected mice are a consequence of transcriptionally similar host responses to each virus. Using 295 DAVID-based functional clustering, we identified multiple statistically significant functional 296 clusters within this set of 2,879 genes that are implicated in signaling cascades, the general immune 297 response, and transcriptional regulation. These analyses reveal substantial upregulation in 298 expression of many proinflammatory genes, including well-known players TNF, IL-6, IL-1b, 299 CXCL-10, CXCL-11, and CCL3 (Fig 8) . We noted significant differences in the activation of these 300 genes associated with a proinflammatory response in BMDMs infected with either the wild type 301 virus or DUBmut compared to those infected with EndoUmut. Potent activation of these genes by 302 12 hpi may stimulate recruitment of inflammatory mediators directed at tissue repair [26] . In involved in lipid synthesis and amino acid transport ( Fig 9A) . Based on our analyses of differential 311 gene expression, we report significant transcriptional upregulation of multiple genes associated 312 with activation of ER sensors IRE1, ATF6, and PERK, such as Edem1, Hspa5 (encoding BiP 313 protein), and Ddit3 (encoding CHOP), in response to virus replication, with the most robust 314 response detected in cells infected with the wild type or DUBmut virus (Fig 9 B, C, and D) . Here, we report that inactivation of a coronaviral interferon antagonist, EndoU, profoundly 321 alters the host response to viral replication in macrophages. We find that the EndoUmut virus 322 elicits a rapid, robust, and specific antiviral response that was effective in limiting virus replication.
323
In contrast, our data show that the WT and DUBmut viruses ultimately elicit very similar host 324 responses that are both characteristic of an unfolded protein response and consistent with a 325 proinflammatory profile that is associated with viral pathogenesis [27] . The results from the 326 DUBmut-infected macrophages indicate that the mere induction of type I IFN is not a sufficient 327 marker for attenuation of the virus. Instead, these results suggest that the timing and the magnitude 328 of the host antiviral response are critical for determining the outcome of infection in macrophages.
329
Our observation that the EndoUmut virus induces an earlier and more profoundly elevated type I 330 interferon response than even the DUBmut virus implies that there is a threshold of IFN expression 331 that must be breached before the cell mounts an effective antiviral response.
332
The structure-guided approach used to generate the DUBmut virus allowed for 333 characterization of three different classes of mutant enzymes: Class I, deficient in both DUB and 334 de-ISGylating activity; Class II, deficient in de-ISGylating activity only; and Class III, deficient 335 in DUB activity but competent in protease and de-ISGylating activity. We utilized three unique 336 biochemical substrates, each with a conjugated fluorescent AMC reporter, to evoke the multi-functional activities of PLP2. Activity against the z-RLRGG-AMC peptide substrate represents 338 the polyprotein processing activity of MHV PLP2, while UB-AMC and ISG15-AMC stimulate 339 the deubiquitinating and deISGylating activities of the enzyme, respectively. The kinetic data for 340 the D1772A DUBmut hydrolysis of the z-RLRGG-peptide provided in Figure 2B indicate that the 341 polyprotein processing ability of this mutant is likely not affected by the D1772A substitution. The 342 deISGylating ability of the enzyme is also not affected. In contrast, the mutant enzyme's 343 deubiquitinating activity is significantly reduced relative to wild type, which is most likely due to 344 a lowered binding affinity for ubiquitin as the enzyme could not be saturated with Ub-AMC as a 345 substrate. 346 We were able to reproduce the enzymatic profile of the purified PLP2-D1772A mutant 347 protein when we expressed it in cell culture (Fig 3) . Therefore, our finding that the DUBmut virus [28]; therefore, we anticipated a more remarkable phenotype for a DUB-mutant virus. We can 353 imagine several possible explanations for our findings. First, it is possible that viral DUB activity 354 has a relatively minor role in shaping pathogenesis in this system. In fact, our recent studies using 355 SARS-CoV and SARS-related CoVs found that the papain-like protease domain/DUB is a 356 virulence trait that varies among members of the SARS-coronavirus species [9] . In that study, we 357 found that replacing the SARS PLP2/DUB domain with a SARS-related PLP2/DUB domain 358 reduced the ability of that virus to antagonize the innate immune response. Together, this previous 359 report in conjunction with the current study support the concept that different PLP2/DUB domains may have distinct effects on antagonism of the innate immune response depending on the virus 361 and the host cell type. Another possibility is that the DUB-mutant virus we generated may not have 362 been sufficiently debilitated in its DUB activity to result in altered pathogenesis. We found that it 363 was difficult to recover viable DUB-mutant viruses; indeed, this D1772A mutant was the sole 364 viable DUB-mutant representative of our many attempts. Because an elevated interferon response 365 was elicited from DUBmut-infected cells, this mutant virus fulfilled our criteria demonstrating the 366 inactivation of an interferon antagonist. However, we speculate that if we are able to recover 367 mutants that exhibit a range of DUB activity, we may be able to more fully assess the role of DUB 368 activity as a contributor to coronaviral pathogenesis. Despite these caveats, the MHV DUB-mutant 369 generated in this study did exhibit a reproducible phenotype of eliciting an elevated interferon 370 response in infected macrophages that was associated with mild attenuation of pathogenesis with 371 reduced titers in the livers and spleens of mice at day 5 post-infection. Overall, we conclude that 372 DUB activity is indeed a virulence trait, but not a major driver of virulence for MHV. Our results 373 support the concept that multiple viral factors likely work in concert to shape and ultimately limit 374 the innate immune response to coronavirus replication.
375
The other remarkable finding from this study was the distinct transcriptional profile elicited 376 by the EndoUmut virus during infection of bone marrow-derived macrophages compared to the 377 profiles of wild type-and DUBmut-infected cells (Fig 6) . We detected elevated levels of interferon 378 and interferon-responsive genes as early as 6-9 hpi, with EndoUmut-infected cells exhibiting by 379 far the highest expression levels of these genes. We and others found that an antiviral response to 380 EndoUmut infection results in activation of apoptosis, which subsequently limits virus replication 381 in cell culture and in infected mice [10, 11] . The current study indicates that screening MHV 382 mutants in interferon-responsive cells may be an effective approach to identifying strains that 18 383 stimulate a robust innate immune response, which may then restrict virus replication in animals.
384
Previous studies of coronavirus-encoded interferon antagonists focused on evaluating the host [29] [30] [31] [32] [33] . Each of these interferon antagonists may play 19 406 either a cell-or tissue-type specific role, or act in concert with other factors during viral replication 407 to mitigate the innate immune response. Further studies are needed to fully understand if all or 408 only a subset of these antagonists must be silenced to generate an effective, live-attenuated vaccine.
409
The results presented here and from the study of the MERS-CoV dORF3-5 mutant virus indicate 410 that inactivating interferon antagonists and screening for an early and robust antiviral 411 transcriptional profile may represent an efficient and informative approach to evaluating live-412 attenuated vaccine candidate strains for existing and emerging coronaviruses. particles places a substantial load on the host translational machinery during infection. Host 419 sensors IRE1, ATF-6, and PERK are situated in the ER to sense and respond to such overload by 420 prompting upregulated expression of genes encoding ER chaperones, amino acid transporters, and 421 activators of lipid biosynthesis. Ironically, many of these proteins ultimately facilitate virus 422 replication and assembly. Notably, it has been demonstrated that UPR pathways that promote
